 |
BioWorld-Insight-2003-07-07
Stock Winners and Losers For The Week
With Xolair Approved, Trio Sorts Options For Peanut Allergy Drug
Last month, when the FDA approved Xolair for asthma, there was much rejoicing by Genentech Inc., Tanox Inc. and Novartis Pharma AG, which developed the monoclonal antibody in a three-way deal.